Independent psychedelic field guideEducational information — not medical adviceOur research standards
Conditions & questions · 07 paths

Start with
the why.

Sometimes the medicine is the starting point. Sometimes it is grief, pain, trauma, habit, disconnection, or the hope that life could feel different.

This map shows associations and research questions—not treatment recommendations.
CONNECTION IS NOT A CLAIM

A medicine appears here because it is part of current research, established clinical practice in a specific context, or sustained public interest. That does not mean it is approved for the condition—or a good fit for every person.

02
Fear · uncertainty · serious illness

Anxiety & distress

Studies often focus on anxiety linked to depression, serious illness, or existential distress rather than treating every kind of anxiety as one category.

03
Trauma · memory · therapeutic support

PTSD

The most developed psychedelic-adjacent research centers on MDMA-assisted therapy, where the medicine and structured therapeutic process are studied together.

04
Connection · safety · belonging

Social anxiety

Small and early studies have explored whether entactogenic effects may support work with social fear in specific populations.

05
Pain · perception · nervous system

Chronic pain

Ketamine is used clinically in some pain settings, while protocols, evidence quality, access, and suitability vary by pain condition.

07
Dependence · withdrawal · recovery

Opioid-use disorder & addiction

Ibogaine attracts significant interest and personal testimony, but evidence remains preliminary and cardiac risk makes this a particularly high-stakes area.

A NOTE FOR GUIDES & FACILITATORS

The question behind the question matters.

Diagnosis labels are only one layer. Intent, expectations, culture, support, medications, physical health, previous experiences, and what happens afterward can matter just as much to the shape of an experience.